Your browser is no longer supported. Please, upgrade your browser.
Settings
RGEN [NASD]
Repligen Corporation
Index- P/E122.28 EPS (ttm)0.25 Insider Own2.10% Shs Outstand32.78M Perf Week-5.41%
Market Cap1.00B Forward P/E67.48 EPS next Y0.45 Insider Trans-24.17% Shs Float30.97M Perf Month16.68%
Income8.20M PEG- EPS next Q0.08 Inst Own93.50% Short Float13.99% Perf Quarter54.08%
Sales63.50M P/S15.78 EPS this Y-50.00% Inst Trans6.33% Short Ratio11.19 Perf Half Y58.07%
Book/sh3.37 P/B9.07 EPS next Y46.13% ROA9.90% Target Price29.67 Perf Year138.46%
Cash/sh1.78 P/C17.13 EPS next 5Y- ROE11.10% 52W Range12.18 - 34.15 Perf YTD54.39%
Dividend- P/FCF77.68 EPS past 5Y31.40% ROI6.80% 52W High-10.25% Beta1.00
Dividend %- Quick Ratio6.40 Sales past 5Y24.80% Gross Margin55.90% 52W Low151.64% ATR1.70
Employees136 Current Ratio7.60 Sales Q/Q6.50% Oper. Margin20.20% RSI (14)59.15 Volatility6.74% 6.38%
OptionableYes Debt/Eq0.00 EPS Q/Q-110.00% Profit Margin19.70% Rel Volume0.64 Prev Close30.57
ShortableYes LT Debt/Eq0.00 EarningsMar 13 BMO Payout0.00% Avg Volume387.03K Price30.65
Recom1.00 SMA207.25% SMA5016.37% SMA20033.98% Volume233,634 Change0.26%
Mar-07-11Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Jun-30-09Initiated Merriman Buy
Jun-12-08Reiterated Rodman & Renshaw Mkt Outperform $11 → $9
Sep-10-07Reiterated Rodman & Renshaw Mkt Outperform $6 → $8
Apr-12-07Reiterated Rodman & Renshaw Mkt Outperform $5 → $6
Mar-24-15 01:04PM  REPLIGEN CORP Financials
Mar-20-15 08:21AM  Repligen (RGEN) Enters Overbought Territory - Tale of the Tape
Mar-17-15 05:24PM  REPLIGEN CORP Files SEC form 10-K, Annual Report
Mar-13-15 07:27AM  Repligen reports 4Q loss +16.74%
07:22AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:21AM  Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance at noodls
07:07AM  Q4 2014 Repligen Corp Earnings Release - Before Market Open
07:00AM  Repligen Reports Financial Results for the Year 2014 and Issues 2015 Financial Guidance GlobeNewswire
Mar-09-15 03:44PM  Repligen to Report Year 2014 Financial Results and Provide 2015 Financial Guidance at noodls
03:09PM  Repligen to Report Year 2014 Financial Results and Provide 2015 Financial Guidance GlobeNewswire
Mar-02-15 07:47AM  REPLIGEN CORP Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibits
Feb-10-15 07:30AM  Repligen Completes Expansion of U.S. Facility GlobeNewswire
Feb-04-15 07:30AM  Repligen to Present at 2015 Leerink Global Healthcare Conference GlobeNewswire
Jan-30-15 07:31AM  REPLIGEN CORP Files SEC form 8-K, Termination of a Material Definitive Agreement
Jan-26-15 09:31AM  Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape
Jan-23-15 04:31PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat
Jan-21-15 07:07AM  Repligen Corporation Names Tony Hunt as Next Chief Executive Officer at noodls
07:00AM  Repligen Corporation Names Tony Hunt as Next Chief Executive Officer GlobeNewswire
Jan-09-15 11:47AM  Here are the best-performing stocks so far in 2015 at MarketWatch
Jan-08-15 07:42AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online +23.09%
07:30AM  Repligen Receives Milestone Payment From Pfizer GlobeNewswire
Nov-12-14 07:30AM  Repligen to Present at Stifel Healthcare Conference 2014 GlobeNewswire
Nov-10-14 07:08PM  10-Q for Repligen Corp. Company Spotlight
Nov-07-14 11:37AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-06-14 10:15AM  Repligen posts 3Q profit AP -5.08%
07:59AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  Repligen Reports Third Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q3 2014 Repligen Corp Earnings Release - Before Market Open CCBN
Nov-05-14 01:17PM  Repligen to Present at Stephens Inc. Fall Investment Conference GlobeNewswire
Oct-23-14 07:30AM  Repligen to Report Third Quarter 2014 Financial Results GlobeNewswire
Oct-10-14 11:23AM  Repligen to Host Investor & Analyst Event on October 16 GlobeNewswire
Sep-26-14 01:04PM  Nike Jumps On Strong Results; Powell Industries Shares Slide Benzinga
Aug-18-14 11:07AM  REPLIGEN CORP Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi EDGAR Online +6.73%
Aug-11-14 07:28AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2014 Repligen Corporation Earnings Release - Before Market Open CCBN
07:00AM  Repligen Reports Second Quarter 2014 Financial Results GlobeNewswire
Jul-28-14 07:30AM  Repligen to Report Second Quarter 2014 Financial Results GlobeNewswire
Jul-15-14 03:17PM  CFO Moves: Repligen Corp., Top Image Systems Ltd. at The Wall Street Journal
07:51AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
07:30AM  Repligen Hires Jon K. Snodgres as Chief Financial Officer GlobeNewswire
Jul-02-14 01:48PM  3 Stocks to Get on Your Watchlist at Motley Fool
Jul-01-14 05:05PM  On The Fly: Closing Wrap at theflyonthewall.com
Jun-27-14 08:17AM  Repligen (RGEN) Shares March Higher, Can It Continue? Zacks
Jun-12-14 09:52AM  Repligen Appoints Nicolas M. Barthelemy to Board of Directors GlobeNewswire
08:05AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Jun-04-14 03:22PM  Why Repligen Corporation Shares Vaulted Higher at Motley Fool +6.89%
Jun-03-14 09:00AM  Repligen Corp Conference Call to discuss the acquisition of Bioprocessing Business of Refine Technology scheduled for 9:00 am ET today CCBN
08:01AM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio EDGAR Online
07:00AM  Repligen Acquires Bioprocessing Business of Refine Technology GlobeNewswire
May-28-14 04:15PM  Repligen to Present at Jefferies 2014 Global Healthcare Conference GlobeNewswire
May-19-14 06:37PM  Should a Soaring Market Cap Worry Repligen Corporation Investors? at Motley Fool
12:12PM  Repligen management to meet with Jefferies at theflyonthewall.com
08:01AM  REPLIGEN CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matt EDGAR Online
May-11-14 04:35PM  Surges In Biotech Short Interest (INCY, PCYC, RGEN) Benzinga
May-09-14 11:10AM  REPLIGEN CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
May-08-14 01:52PM  Why Repligen Corporation Shares Briefly Spiked Higher at Motley Fool
08:30AM  Repligen Corporation Earnings Call scheduled for 8:30 am ET today CCBN
07:46AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:17AM  Repligen backs FY14 revenue view $54M-$57M, consensus $55.2M at theflyonthewall.com
07:15AM  Repligen reports Q1 EPS 13c, consensus 9c at theflyonthewall.com
07:07AM  Q1 2014 Repligen Corporation Earnings Release - Before Market Open CCBN
07:00AM  Repligen Reports First Quarter 2014 Financial Results GlobeNewswire
May-06-14 07:10AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Stat EDGAR Online
May-03-14 12:29PM  Repligen: A Strong Investment For The Right Kind Of Investor at Seeking Alpha
Apr-25-14 02:03PM  Repligen to Report First Quarter 2014 Financial Results GlobeNewswire
Apr-19-14 12:48PM  3 Humongous Health-Care Stocks This Week at Motley Fool
Apr-15-14 05:53PM  Repligen Corporation Set to Join the S&P SmallCap 600 PR Newswire +5.12%
Apr-08-14 08:05AM  3 Stocks Spiking on Unusual Volume at TheStreet
Mar-26-14 07:30AM  Repligen Launches OPUS(R) Ready-to-Use Chromatography Columns With Largest Capacity Available on the Market GlobeNewswire
Mar-21-14 08:31AM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
Mar-14-14 11:51AM  REPLIGEN CORP Files SEC form 10-K, Annual Report EDGAR Online
Mar-06-14 01:53PM  Why Repligen Corporation Shares Were Slammed at Motley Fool -8.52%
10:40AM  Repligen Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:00AM  Repligen Corporation Earnings Call scheduled for 9:00 am ET today CCBN
08:01AM  REPLIGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  Repligen Reports Full Year and Fourth Quarter 2013 Financial Results GlobeNewswire
07:07AM  Q4 2013 Repligen Corporation Earnings Release - Before Market Open CCBN
Feb-25-14 07:30AM  Repligen to Report Fourth Quarter and Fiscal Year 2013 Financial Results GlobeNewswire
Jan-22-14 06:37PM  Lightning Round: Caterpillar, LinkedIn & More at CNBC +8.86%
04:26PM  Why Repligen Corporation Shares Jumped at Motley Fool
Jan-21-14 03:03PM  REPLIGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and EDGAR Online
11:12AM  Repligen, Continuing Overhaul, Flips Rare Disease Drugs to BioMarin at Motley Fool
07:30AM  Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio GlobeNewswire
Jan-20-14 02:12PM  Apples To Apples: Organovo Vs. Repligen at Seeking Alpha
Jan-12-14 07:08AM  How Will the Bottom Line Change for Repligen in 2014? at Motley Fool
Jan-10-14 11:42AM  How Will the Top Line Change for Repligen in 2014? at Motley Fool
Jan-01-14 12:03PM  3 Health Care Investments Immune From FDA Scrutiny at Motley Fool
Dec-13-13 10:08AM  What Should Investors Expect From Repligen in 2014? at Motley Fool
Dec-05-13 10:04PM  Fundamentally Attractive Biotechnology "Pick & Shovel" Companies at Seeking Alpha
Nov-26-13 07:30AM  Repligen to Present at the 25th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-24-13 01:55PM  Repligen-My Projections For The Income Statement: 2013 -2019 at Seeking Alpha
Nov-22-13 02:01PM  5 Biotech Trends Powering Repligen's Growth at Motley Fool
Nov-19-13 04:48PM  The Simplest Biotech Growth Portfolio Ever at Motley Fool
04:12PM  REPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
02:58PM  Repligen names Biogen executive to its board AP
02:00PM  Repligen Appoints Biogen Idec Executive John G. Cox to Board of Directors GlobeNewswire
Nov-17-13 08:46PM  Repligen's 3 Most Important Customers at Motley Fool
Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. The company manufactures various forms of Protein A, a critical reagent used in biomanufacturing to separate and purify monoclonal antibodies. It also supplies various growth factor and cell filtration products, which are used to increase cell growth and productivity during the fermentation step of biomanufacturing, and chromatography products for purification of biologic products. In addition, the company manufactures and sells chromatography products, including OPUS pre-packed columns for biologics purification, as well as proprietary Protein A media and quality control test kits. Further, it has a portfolio of therapeutic product candidates, which include histone deacetylase inhibitor for the treatment of Friedreich's ataxia disease; and RG1068, a synthetic human hormone developed as a novel imaging agent for the detection of pancreatic duct abnormalities in combination with magnetic resonance imaging in patients with pancreatitis and other pancreatic diseases. Additionally, Repligen Corporation offers alternating tangential flow system, a filtration device used to improve product yield during the fermentation step of the biologic drug manufacturing process. The company sells its bioprocessing products directly and through distributors to various life sciences companies, biopharmaceutical manufacturing companies, and contract manufacturing organizations worldwide. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HERLIHY WALTER CPRESIDENT AND CEOMar 23Sale31.7623,686752,173422,430Mar 23 06:32 PM
HERLIHY WALTER CPRESIDENT AND CEOMar 20Sale32.5185027,629446,116Mar 23 06:32 PM
HERLIHY WALTER CPRESIDENT AND CEOMar 19Sale33.0849,6951,643,762446,966Mar 20 04:50 PM
RYAN THOMAS F JRDirectorMar 19Sale32.6210,000326,18740,312Mar 20 04:50 PM
RUSCHE JAMES RSenior Vice PresidentMar 19Sale33.3014,650487,845111,849Mar 25 08:05 PM
Benjamin HowardVP Business DevelopmentMar 18Option Exercise8.9013,807122,86962,349Mar 19 05:41 PM
Benjamin HowardVP Business DevelopmentMar 18Sale32.6315,795515,44346,554Mar 19 05:41 PM
HERLIHY WALTER CPRESIDENT, CEONov 19Sale22.954,15895,426496,661Nov 20 03:32 PM
HERLIHY WALTER CPRESIDENT, CEONov 18Sale23.4747,2281,108,441500,819Nov 20 03:32 PM
HERLIHY WALTER CPRESIDENT, CEONov 14Option Exercise3.3310,00033,300549,477Nov 18 02:56 PM
Benjamin HowardVP Business DevelopmentNov 11Sale23.5630,000706,80043,851Nov 12 03:53 PM
GRIFFITH MICHAEL ADirectorNov 10Option Exercise4.5316,00072,48025,274Nov 12 03:08 PM
GRIFFITH MICHAEL ADirectorNov 10Sale22.9023,342534,5581,932Nov 12 03:08 PM
Benjamin HowardVP Business DevelopmentAug 13Option Exercise3.335,00016,650113,851Aug 14 04:26 PM
Benjamin HowardVP Business DevelopmentAug 13Sale20.3440,000813,79273,851Aug 14 04:26 PM
RYAN THOMAS F JRDirectorJun 27Option Exercise4.1310,00041,30055,312Jul 01 08:12 AM
RYAN THOMAS F JRDirectorJun 27Sale22.4110,000224,13050,312Jul 01 08:12 AM
RYAN THOMAS F JRDirectorJun 24Option Exercise4.9610,00049,60060,312Jun 25 02:04 PM
RYAN THOMAS F JRDirectorJun 24Sale21.7810,000217,78050,312Jun 25 02:04 PM
WITT DANIEL PSenior Vice PresidentJun 20Option Exercise4.9087,500428,62580,833Jun 24 09:38 AM
HERLIHY WALTER CPRESIDENT, CEOJun 11Sale20.1160,3351,213,584539,477Jun 12 04:09 PM
RUSCHE JAMES RSenior Vice PresidentJun 09Sale20.1930,000605,730121,270Jun 10 12:09 PM
WITT DANIEL PSenior Vice PresidentJun 06Sale20.5647,709980,70610,000Jun 09 01:36 PM
Benjamin HowardVP Business DevelopmentJun 05Option Exercise4.40102,036448,853115,962Jun 09 01:35 PM
RYAN THOMAS F JRDirectorJun 05Option Exercise4.7245,000212,20070,312Jun 09 03:56 PM
RYAN THOMAS F JRDirectorJun 05Sale20.5645,000925,08850,312Jun 09 03:56 PM
RUSCHE JAMES RSenior Vice PresidentApr 15Buy3.0525,00076,250151,270Apr 15 04:53 PM
WITT DANIEL PSenior Vice PresidentApr 15Buy3.0510,00030,50057,709Apr 15 04:51 PM